Pharma Turkey Dergisi Mayıs- Haziran 2017 Sayısı
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
4.3 Million TL investment in early stage domestic smart<br />
medicine technology<br />
Technology Transfer Accelerator<br />
Program (TTHP), which SEHIR<br />
Technology Transfer Office<br />
has been implementing since 2015,<br />
continues to receive successful<br />
results. So far, many entrepreneurial<br />
initiatives have opened the door to<br />
early stage technology investment,<br />
and SEHIR TTO has again supported<br />
RS Research İlac A.S. (RS<br />
Research), which researches and<br />
develops targeted cancer drugs<br />
and drug delivery methods. RS<br />
Research, which came together<br />
with investors after the Technology<br />
Transfer Accelerator Program for<br />
the commercialization of technology<br />
under the management of TTO,<br />
succeeded to invest 4.3 million TL<br />
from the ACT Early Stage Technology<br />
Fund, which invests in early-stage<br />
technology in <strong>Turkey</strong>. RS Research<br />
plans to use the investment to<br />
develop various cancer drug<br />
molecules to be applied by patented<br />
‘drug carrier’ technology and to<br />
conduct human clinical trials.<br />
Patented pharmaceutical<br />
technology brings a new solution<br />
that will reduce side effects<br />
Cancer drugs to be developed<br />
by RS Research’s patented drug<br />
carrier technology can be passed<br />
on to a much larger number of<br />
cells and more than one different<br />
tumor-bearing cells. In this way,<br />
the effectiveness of the medicine<br />
increases with the cancer, and<br />
the side effects such as hair loss,<br />
fatigue, negativities in other organs<br />
are minimized. Decreased side<br />
effects and shortened duration of<br />
treatment increase the quality of life<br />
of cancer patients.<br />
The number of cancer cases is<br />
expected to increase by 70% by<br />
2030<br />
According to the World Health<br />
Organization, 14 million new<br />
patients and more than 8 million<br />
deaths each year are the leading<br />
cause of death worldwide. Experts<br />
say that by 2030, they expect to<br />
see a 70% increase in annual new<br />
cases of cancer. There are many<br />
different ways to treat cancer.<br />
However, the drugs used for cancer<br />
treatment also damage healthy cells<br />
other than cancer cells, and the<br />
patients who have cancer treatment<br />
experience various side effects and<br />
discomfort during the treatment and<br />
the quality of life is decreasing.<br />
<strong>Pharma</strong><br />
May- June ‘17 23
Change language